358P - Complete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell activation with off-the-shelf high-affinity CD16 NK cell line (haNK)
| Autor: | Nangia, C., Soon-Shiong, P., Rabizadeh, S., Lee, J.H., Sender, L., Jones, F., Kistler, M., Niazi, K., Seery, T., Rock, A., Jafari, O. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v130-v130 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|